TY - JOUR AU - Martorell, A AU - Alonso, E AU - Echeverria, L AU - Escudero, C AU - Garcia-Rodriguez, R AU - Blasco, C AU - Bone, J AU - Borja-Segade, J AU - Bracamonte, T AU - Claver, A AU - Corzo, J L AU - De-la-Hoz, B AU - Del-Olmo, R AU - Dominguez, O AU - Fuentes-Aparicio, V AU - Guallar, I AU - Larramona, H AU - Martin-Muñoz, F AU - Matheu, V AU - Michavila, A AU - Ojeda, I AU - Ojeda, P AU - Piquer, M AU - Poza, P AU - Reche, M AU - Rodriguez-Del-Rio, P AU - Rodriguez, M AU - Ruano, F AU - Sanchez-Garcia, S AU - Terrados, S AU - Valdesoiro, L AU - Vazquez-Ortiz, M PY - 2017 DO - 10.18176/jiaci.0177 SN - 1018-9068 UR - http://hdl.handle.net/10668/11427 T2 - Journal of investigational allergology & clinical immunology AB - Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg... AB - Introducción: El huevo y la leche de vaca son la causa más frecuente de alergia alimentaria en los primeros años de vida. Como alternativa terapéutica a la dieta de eliminación se han investigado otras formas de tratamiento como la inmunoterapia oral... LA - en PB - Esmon Publicidad KW - Desensitization KW - Egg allergy KW - Guide KW - Milk allergy KW - Omalizumab KW - Oral immunotherapy KW - Specific oral tolerance induction KW - Sublingual immunotherapy KW - Guía KW - Inmunoterapia oral KW - Desensibilización KW - Inducción de tolerancia oral específica KW - Alergia a leche KW - Alergia a huevo KW - Inmunoterapia sublingual KW - Administration, Oral KW - Allergens KW - Desensitization, Immunologic KW - Egg Hypersensitivity KW - Humans KW - Milk Hypersensitivity KW - Practice Guidelines as Topic KW - Spain TI - Oral Immunotherapy for Food Allergy: A Spanish Guideline. Immunotherapy Egg and Milk Spanish Guide (ITEMS Guide). Part I: Cow Milk and Egg Oral Immunotherapy: Introduction, Methodology, Rationale, Current State, Indications, Contraindications, and Oral Immunotherapy Build-up Phase. TY - research article VL - 27 ER -